RDY vs TAK
Dr. Reddy's Laboratories Limited · Takeda Pharmaceutical Company Limited
Relative return (rebased to 100)
Key stats
| Metric | RDY | TAK |
|---|---|---|
| Price | $12.23 | $18.30 |
| Market Cap | $10.20B | $29.11B |
| P/E | 15.39 | — |
| P/B | 2.61 | — |
| P/S | 2.68 | — |
| ROE | 17.0% | — |
| Net Margin | 17.4% | — |
| Gross Margin | 58.5% | — |
| Revenue Growth | 13.8% | — |
| Dividend Yield | — | — |
| EPS | $0.79 | — |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.